CYP1A2 rs2472298: Caffeine Metabolism & Genetics
The genetic variant rs2472298 is a non-coding single-nucleotide polymorphism located in the intergenic region near the CYP1A2 gene on chromosome 15. Research suggests it acts as a regulatory modifier in linkage disequilibrium with other metabolic variants, altering how enzyme production responds to coffee consumption. Because CYP1A2 encodes the primary liver enzyme responsible for clearing caffeine, variations at this locus have been linked to differences in daily coffee intake and caffeine clearance rates.
What each genotype means
Typical caffeine metabolism inducibility
You carry two copies of the C allele at rs2472298. Research shows this background is typically associated with standard baseline CYP1A2 activity and caffeine clearance, though actual metabolism is heavily influenced by non-genetic factors like smoking, diet, and medications. If you have questions about how your body processes prescription drugs metabolized by CYP1A2, discuss proper dosing with your physician or pharmacist.
Carried by approximately 45% to 50% of individuals across global populations, being the most common genotype in European and African ancestries.
Intermediate caffeine metabolism inducibility
You carry one copy of the T allele linked to altered CYP1A2 inducibility in coffee consumers. Evidence regarding this variant is limited and largely reflects modest statistical associations with habitual caffeine intake and metabolic rates rather than definitive health outcomes. Because CYP1A2 also clears several medications, consult your doctor or pharmacist before making any changes to your prescriptions.
Carried by approximately 40% to 45% of individuals globally.
Altered caffeine metabolism inducibility
You carry two copies of the T allele at rs2472298, which is in linkage disequilibrium with regulatory variants altering CYP1A2 enzyme inducibility following regular coffee consumption. Population studies suggest an association with variations in caffeine clearance and habitual intake, though the overall clinical evidence remains limited. Always review any questions regarding drug metabolism or medication dosing with your healthcare provider or pharmacist.
Carried by approximately 5% to 10% of individuals globally, reflecting the ~0.30 minor allele frequency.
What Is rs2472298 and Where Is It Located?
The single-nucleotide polymorphism rs2472298 sits in a non-coding regulatory genomic region on chromosome 15 (15q24), flanked by the CYP1A1 and CYP1A2 gene cluster. Instead of altering protein-coding amino acid sequences directly, variations in this chromosomal locus function as regulatory elements. According to genomic databases such as dbSNP, rs2472298 commonly involves an exchange between cytosine (C) and thymine (T) alleles. This site is frequently found in high linkage disequilibrium with other well-characterized markers in the region, including rs762551 (which defines the CYP1A2*1F allele) and rs2472297. Because it resides in an intergenic promoter and enhancer space, it helps modulate the transcriptional machinery that dictates how much downstream enzyme is synthesized in response to external dietary stimuli.
The Biological Function of the CYP1A2 Enzyme
The CYP1A2 gene provides biological instructions for building cytochrome P450 1A2, a vital hepatic enzyme responsible for metabolizing an estimated 95% of ingested caffeine. Beyond its dietary role, CYP1A2 breaks down several clinically significant pharmaceuticals, such as the muscle relaxant tizanidine, the antidepressant fluvoxamine, and various atypical antipsychotics like clozapine and olanzapine. Unlike static housekeeping genes, CYP1A2 is highly inducible: exposure to dietary xenobiotics found in roasted coffee beans, chargrilled meats, or cigarette smoke triggers receptors such as the aryl hydrocarbon receptor (AHR). This signaling cascade prompts the cell to upregulate CYP1A2 transcription, thereby accelerating the rate at which caffeine and xenobiotic compounds are metabolized and eliminated from circulation.
Published Scientific Evidence and Associations
Large genome-wide association studies cataloged in resources like PubMed and the GWAS Catalog have identified common variants in the CYP1A1-CYP1A2 locus as primary genetic determinants of habitual coffee consumption. Individuals carrying regulatory alleles that correlate with elevated CYP1A2 inducibility frequently exhibit higher daily coffee intake, likely because faster caffeine clearance prompts individuals to consume more cups to maintain equivalent systemic caffeine levels. However, the direct evidence linking rs2472298 alone to standalone clinical outcomes is categorized as limited. Because rs2472298 is co-inherited with neighboring functional variants like CYP1A2*1F, determining its independent biological impact requires careful haplotype deconvolution. Most population-level effects are modest, reflecting subtle adjustments in daily intake rather than total metabolic disruption.
Population Frequency and Ancestral Distribution
Data from large population reference databases like the Genome Aggregation Database (gnomAD) and the 1000 Genomes Project demonstrate that rs2472298 is a common polymorphism worldwide. The minor allele displays an overall global frequency of roughly 0.30, although regional variation exists across distinct ancestral lineages. In European and Admixed American cohorts, allele distribution reflects a robust presence of both major and minor alleles, allowing researchers to readily study heterozygous and homozygous subgroups. Conversely, variation frequencies may differ in East Asian or African populations due to historical drift and differing linkage disequilibrium patterns across the broader 15q24 gene cluster. This ancestral variance highlights the importance of evaluating genetic architecture within appropriate demographic contexts.
Interpreting Results: What You Can and Cannot Do
Discovering your rs2472298 genotype provides curious educational context regarding your biological response to dietary caffeine and your tendencies toward coffee consumption. However, this non-coding marker is neither a diagnostic test nor a definitive guide to personal wellness. Lifestyle factors—including smoking status, oral contraceptive use, liver health, and overall diet—exert profound effects on CYP1A2 expression that can outweigh modest genetic predispositions. Furthermore, rs2472298 should never be used to alter prescription medication regimens independently. If you are taking drugs metabolized by CYP1A2 or have concerns about medication-caffeine interactions, always consult a licensed physician or clinical pharmacist for professional guidance.
How common is this variant?
The minor allele frequency for rs2472298 is approximately 0.30 across global populations, with heterozygous and homozygous genotypes commonly observed across European, American, and other continental cohorts.
Frequently asked questions
Does having the rs2472298 variant make me a fast caffeine metabolizer?
Not on its own. While rs2472298 is in strong linkage disequilibrium with variants linked to high enzyme inducibility, true caffeine clearance is dictated by full haplotype combinations and environmental exposures such as diet or smoking. It serves as a statistical indicator rather than a definitive measure of speed.
Can my rs2472298 genotype affect how I process prescription drugs?
The CYP1A2 enzyme metabolizes several key prescription medications, including clozapine and tizanidine. However, clinical dosing guidelines rely on comprehensive clinical panels and full phenotypic assessments rather than single non-coding markers like rs2472298. Never modify your prescription medications without guidance from your healthcare provider.
Why do people with alleles for rapid caffeine clearance drink more coffee?
Individuals whose liver enzymes break down caffeine quickly clear the stimulant from their circulation in a shorter timeframe. Because the physiological effects wear off faster, these individuals frequently consume additional cups throughout the day to sustain alertness, driving higher self-reported coffee intake in genome-wide studies.
Can I use this genetic result to decide my daily caffeine limit?
No, genetic variants only capture a minor fraction of overall caffeine sensitivity. Your cardiovascular health, sleep patterns, anxiety levels, and total tolerance are far better practical indicators for setting daily limits than an individual non-coding SNP.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2472298?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CYP1A2
This variant in the CYP1A2 gene influences the hepatic metabolism rate of caffeine and is a key marker for individual differences in caffeine clearance.
Intronic marker associated with CYP1A2 enzyme activity and caffeine metabolism rates.
Modulates CYP1A2 inducibility affecting the rate of caffeine metabolism and clearance.
Regulatory variant associated with CYP1A2 enzyme activity, influencing the rate of caffeine metabolism and habitual coffee consumption.
A common variant in the CYP1A2 gene associated with caffeine metabolism rates.
Located in intron 1 of CYP1A2, this variant modulates inducible enzyme activity, altering systemic caffeine clearance and individual susceptibility to caffeine-related blood pressure increases.